AgomAb Therapeutics H1 EPS $(0.93)

Benzinga Newsdesk www.benzinga.com Negative 96.9%

Neg 96.9% Neu 0% Pos 0%

AgomAb Therapeutics (NASDAQ:AGMB) reported quarterly losses of $(0.93) per share.

Comments

No comments yet. Be the first!